{{expand|time=2014-03-10T11:54:39+00:00}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 458612013
| IUPAC_name = 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
| image = Celecoxib.svg
| alt = Skeletal formula of celecoxib
| width = 220
| image2 = Celecoxib-3D-spacefill.png
| alt2 = Space-filling model of celecoxib
<!--Clinical data-->
| tradename = Celebrex
| Drugs.com = {{drugs.com|monograph|celecoxib}}
| MedlinePlus = a699022
| pregnancy_AU = B3
| pregnancy_US =  C

| legal_AU = S4 
| legal_US = Rx-only
| routes_of_administration = Oral
| licence_US = Celebrex

<!--Pharmacokinetic data-->
| bioavailability = 40%
| protein_bound = 97% (mainly to [[serum_albumin|serum albumin]])
| metabolism = Hepatic (mainly [[CYP2C9|CYP2C9]])
| elimination_half-life = ~11 h
| excretion = Renal 27%, [[feces|faecal]] 57%

<!--Identifiers-->
<!-- | CASNo_Ref = {{cascite|correct|CAS}} -->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 169590-42-5
| ATC_prefix = L01
| ATC_suffix = XX33
| ATC_supplemental =  {{ATC|M01|AH01}}
| PubChem = 2662
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
 | DrugBank = DB00482
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2562
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = JCX84Q7J1L
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00567
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 41423
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 118

<!--Chemical data-->
 | C=17 | H=14 | F=3 | N=3 | O=2 | S=1 
| molecular_weight = 381.373 g/mol
| smiles = O=S(=O)(c3ccc(n1nc(cc1c2ccc(cc2)C)C(F)(F)F)cc3)N
<!-- | InChI = 1/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25) -->
<!-- | InChIKey = RZEKVGVHFLEQIL-UHFFFAOYAD -->
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RZEKVGVHFLEQIL-UHFFFAOYSA-N
}}
{{medical}}
'''塞来昔布'''（{{lang-en|Celecoxib}}），商品名'''希樂葆'''或'''西乐葆'''，是一种[[磺酰胺|磺酰胺]][[非類固醇消炎止痛藥|非類固醇消炎止痛藥]]（NSAID）及选择性{{le|COX-2抑制剂|COX-2 inhibitor}}, 用于治疗[[骨关节炎|骨关节炎]]、[[类风湿性关节炎|类风湿性关节炎]]、[[急性疼痛|急性疼痛]]、痛经<ref>[https://www.pfizer.com.tw/upload/product/00000015/Description1/Celebrex_200mg_LLD_USPI_201806-3s.pdf 希樂葆膠囊] {{Wayback|url=https://www.pfizer.com.tw/upload/product/00000015/Description1/Celebrex_200mg_LLD_USPI_201806-3s.pdf |date=20191017032726 }} 輝瑞大藥廠.</ref>，以及减少{{le|家族性腺瘤性息肉病|familial adenomatous polyposis}}患者的结肠和直肠息肉数量。

{{化疗药物}}
{{Anti-inflammatory products}}
{{镇痛药}}

[[Category:抗肿瘤药|Category:抗肿瘤药]]
[[Category:COX-2抑制劑|Category:COX-2抑制劑]]
[[Category:非甾体抗炎药|Category:非甾体抗炎药]]
[[Category:有机氟化合物|Category:有机氟化合物]]
[[Category:辉瑞|Category:辉瑞]]
[[Category:吡唑|Category:吡唑]]
[[Category:磺胺|Category:磺胺]]
[[Category:輝瑞產品|Category:輝瑞產品]]
[[Category:三氟甲基化合物|Category:三氟甲基化合物]]